Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityDividends payablesLiabilities and Shareholders EquityLoans - Loss AllowanceLoans - NetLoans - NetMortgage LoansNon-Current DebtPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Advanced Flower Capital (AFCG) Cash & Equivalents (2021 - 2026)

Advanced Flower Capital has reported Cash & Equivalents over the past 5 years, most recently at $38.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 62.74% year-over-year to $38.6 million; the TTM value through Dec 2025 reached $38.6 million, down 62.74%, while the annual FY2025 figure was $38.6 million, 62.74% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $38.6 million at Advanced Flower Capital, down from $45.1 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $170.3 million in Q2 2024 and troughed at $3.3 million in Q1 2025.
  • A 5-year average of $77.7 million and a median of $82.1 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 107.48% in 2024 and later plummeted 98.0% in 2025.
  • Year by year, Cash & Equivalents stood at $109.2 million in 2021, then increased by 28.49% to $140.4 million in 2022, then tumbled by 35.61% to $90.4 million in 2023, then rose by 14.64% to $103.6 million in 2024, then plummeted by 62.74% to $38.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for AFCG at $38.6 million in Q4 2025, $45.1 million in Q3 2025, and $3.4 million in Q2 2025.